CIK 0001427570 · <br>Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-02 | Young Donald R VP of Quality Assurance | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2019-01-02 | Hussainy Nooshin VP of Finance | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-01-02 | VandenBerg Amy Chief Clinical & Reg Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-01-02 | Plovanic William J. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-01-02 | Huang Kelly Pres & Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 |
Page 10 of 10 · 185 trades